MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $639,274 | -8.4% | 39,855 | +32.4% | 0.05% | -19.0% |
| Q2 2023 | $697,533 | -61.0% | 30,092 | -69.4% | 0.06% | -55.3% |
| Q2 2022 | $1,787,000 | +101.9% | 98,342 | +180.1% | 0.14% | +101.4% |
| Q1 2022 | $885,000 | -39.5% | 35,109 | -33.8% | 0.07% | -23.1% |
| Q4 2021 | $1,464,000 | -30.1% | 53,046 | -18.2% | 0.09% | -29.5% |
| Q3 2021 | $2,094,000 | -56.9% | 64,863 | -59.2% | 0.13% | -54.9% |
| Q2 2021 | $4,858,000 | – | 158,855 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |